Skip to main content
Turkish Journal of Hematology logoLink to Turkish Journal of Hematology
letter
. 2019 Aug 2;36(3):205–206. doi: 10.4274/tjh.galenos.2018.2018.0214

Pediatric Deep Venous Thrombosis and Pulmonary Embolism: Can It Be Antiphospholipid Syndrome?

Pediatrik Derin Ven Trombozu ve Pulmoner Emboli: Antifosfolipid Sendromu Olabilir mi?

Fatma Demir Yenigürbüz 1,*, Hale Ören 1
PMCID: PMC6682786  PMID: 30201599

To the Editor,

In pediatric patients with deep venous thrombosis (DVT) and pulmonary embolism (PE), antiphospholipid syndrome (APS) should be considered early and efforts must be made to ensure timely diagnosis of this potentially life-threatening condition. Pediatric APS is an autoimmune disease characterized by vascular thrombosis and persistently positive antiphospholipid antibodies [1,2,3,4,5]. Primary APS is rarely seen in childhood [4]. A 14-year-old adolescent was admitted with complaints of left upper leg edema for 1 week. On physical examination, obesity, hypertension, and edema of the leg were present. Hyperlipidemia and D-dimer elevation were remarkable. Doppler ultrasonography showed DVT in his left femoral vein and abdominal computed tomography (CT) demonstrated iliac vein thrombosis (Figure 1). Since he had widespread DVT, thorax CT angiography was also performed without any clinical symptoms of PE and it demonstrated filling defects in the right pulmonary artery (Figure 2). Anticoagulation was given and complete recanalization was observed. A diet program was started. When thrombophilia risk factors were evaluated, there was no family history and the genetic thrombophilia panel was negative, LA was positive twice with an interval of 12 weeks (first sample was before treatment), and other APS antibodies were found negative. Systemic lupus erythematosus (SLE) and SLE-like diseases were excluded. The patient was diagnosed with primary APS. Metabolic syndrome was the additional thrombotic risk factor. Long-term anticoagulation therapy (lifetime) was given to the patient.

Figure 1.

Figure 1

Abdominal computed tomography of the patient demonstrating iliac vein thrombosis (arrows).

Figure 2.

Figure 2

Thorax computed tomography angiography of the patient demonstrating filling defects in right pulmonary artery (arrows).

Footnotes

Informed Consent: Received.

Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.

References

  • 1.Yang JY, Chan AK. Pediatric thrombophilia. Pediatr Clin North Am. 2013;60:1443–1462. doi: 10.1016/j.pcl.2013.09.004. [DOI] [PubMed] [Google Scholar]
  • 2.Biss TT. Pulmonary embolism in childhood: how can we be sure not to miss it? Arch Dis Child. 2018;103:814–816. doi: 10.1136/archdischild-2017-314428. [DOI] [PubMed] [Google Scholar]
  • 3.Aguiar CL, Soybilgic A, Avcin T, Myones BL. Pediatric antiphospholipid syndrome. Curr Rheumatol Rep. 2015;17:27. doi: 10.1007/s11926-015-0504-5. [DOI] [PubMed] [Google Scholar]
  • 4.Rumsey DG, Myones B, Massicotte P. Diagnosis and treatment of antiphospholipid syndrome in childhood: a review. Blood Cells Mol Dis. 2017;67:34–40. doi: 10.1016/j.bcmd.2017.02.009. [DOI] [PubMed] [Google Scholar]
  • 5.Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, Kenet G, Koné-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington CA, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert SJ, Wulffraat NM, Ozen S, Brogan P, Kamphuis S, Beresford MW. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann Rheum Dis. 2017;76:1637–1641. doi: 10.1136/annrheumdis-2016-211001. [DOI] [PubMed] [Google Scholar]

Articles from Turkish Journal of Hematology are provided here courtesy of Galenos Yayinevi

RESOURCES